newsfilter
← Latest News
ACCESS Newswire·

NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division

Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman Expands Regulatory Capabilities in Preparation for Proof-of-Concept Study VANCOUVE